New Prebys Foundation grant supports LJI mission to train the next generation of researchers
With this new $300,000 grant, LJI Assistant Professor Miguel Reina-Campos, Ph.D., sets out to make scientific training more accessible
Disease Cancer Immunotherapy and Vaccines
Vijayanand Lab
Pandurangan Vijayanand, M.D., Ph.D., and his lab members employ genomics tools to understand, diagnose and treat pulmonary disease such as asthma, lung cancer and infectious diseases, including the novel coronavirus.
Sharma Lab
Sonia Sharma, Ph.D., and her lab members lead unbiased, genome-scale approaches to unravel innate immunity, the body’s early immune response to microbial pathogens and neoplastic cells.
Sette Lab
Alessandro Sette, Dr.Biol.Sci., defines in chemical terms the specific structures (epitopes) that the immune system recognizes and uses this knowledge to measure and understand immune responses.
Schoenberger Lab
Stephen Schoenberger, Ph.D., is focused on achieving a mechanistic understanding of the generation and regulation of T cell responses in the context of in vivo infection and tumor development.
Rao Lab
Anjana Rao, Ph.D., focuses on understanding how signaling pathways control gene expression, using T cells and other cells of the immune system as models.
Peters Lab
Bjoern Peters, Ph.D., and his lab members are focused on the development of computational tools to address fundamental questions in immunology.
Myers Lab
Samuel Myers, Ph.D., studies the signaling circuits that drive the behavior of individual immune cells and ultimately orchestrate systemic immune responses.
Hogan Lab
Patrick Hogan, Ph.D., studies cells at the nano level – seeking to understand how protein-protein interactions on the submicroscopic scale can have gargantuan impacts on human health and disease.
Croft Lab
Michael Croft, Ph.D., and his team focus on a number of molecules that are members of the tumor necrosis factor (TNF) and tumor necrosis factor receptor (TNFR) family.
Cheroutre Lab
Hilde Cheroutre, Ph.D., and her team study the development, function, and regulation of T lymphocytes, a type of white blood cells.
Postdoctoral Fellow Rachel Helms, Ph.D., awarded 2024 CRI Irvington Postdoctoral Fellowship
LJI scientist aims to answer fundamental questions about the development and maintenance of immune cells to prevent cancer
Reina Lab
Dr. Reina-Campos’ lab seeks to understand the underlying principles governing tissue immune networks that enable robust and long-term protection against infection and tumors.
Ay Lab
Ferhat Ay, Ph.D., works to understand gene regulation in complex organisms and diseases.
LJI scientists develop new method to match genes to their molecular ‘switches’
New research may help scientists hunt down solid tumors and better diagnose disease
LJI home to new “Center of Excellence”
LJI's Flow Cytometry Core brings cutting-edge technology to immune system researchers
Vac to the future
Vaccine researchers take on the challenge of predicting B. pertussis immunization outcomes
A step toward personalized immunotherapy for all
Scientists find evidence that all cancer patients mount an immune response to their tumors, suggesting that many more patients could benefit from personalized immunotherapy
Researchers discover potentially cancer-fighting T cells within some pediatric brain tumor patients
New research suggests a small group of pediatric brain tumor patients may benefit from immunotherapy
A closer look at rebel T cells
LJI researchers investigate a group of T cells known for their unusual response to pathogens
The longer the bootcamp, the better the antibodies
LJI scientists test new vaccine strategy to help the body target HIV
Preparing T cells for the long haul
New LJI research could keep cancer-fighting T cells from burning out before the job is done
Hard-working enzyme keeps immune cells in line
LJI scientists develop new tool for understanding enzymatic activity linked to blood cancers and heart disease
Cancer Immunology
In 2013, Dr. Vijayanand teamed up with Professor Christian Ottensmeier at the Cancer Center, University of Southampton, UK, to set up a large patient-centered cancer immunology program. Our work utilizing genomics tools to study T lymphocytes present in cancer…
Cancer
Immunotherapies for head and neck cancer: To develop new cancer therapies by studying how the immune system, by way of neo-antigens, can recognize and eliminate tumor cells by targeting molecules only found on the surface of the tumor cells. The…
Targeting Tumor Endothelium for Cancer Surveillance and Immunotherapy
Preliminary data from our lab shows that vascular endothelial cells (vECs) mount remarkably potent innate responses to cell-free DNA, which is well in accordance with their role as sentinels of the blood. However, little is known about how the contribution…
